5 research outputs found

    Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

    Get PDF
    Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following Phase

    The Challenge of Measuring Financial Impacts From Investments in Corporate Social Performance

    No full text

    A tecnologia e a realização do trabalho

    No full text
    corecore